iFuse Granite Onyx Implant System
SI-BONE, INC. · Decision date Sep 23, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 23, 2026 for K262067, a traditional 510(k) from SI-BONE, Inc. of Santa Clara, California, covering the iFuse Granite Onyx™ Implant System. The filing lists the implant under 21 CFR 888.3070 (Thoracolumbosacral Pedicle Screw System, Class II, product code NKB), with a subsequent product code of OLO for navigation instruments intended for use with the Medtronic StealthStation System and with Globus ExcelsiusGPS® robotic navigation. The implant is described as Ti-6Al-4V ELI per ASTM F3001, with set screws for 5.0, 5.5 and 6.0 mm titanium alloy or cobalt chrome rods.
The summary states substantial equivalence to cleared predicates on intended use, technological characteristics, materials, manufacturing methods and principles of operation, supported by simulated use and bench testing. The indications span skeletally mature and skeletally immature patients as an adjunct to fusion, with pediatric fixation limited to a posterior approach. SESE is a clearance, not a PMA approval. The summary does not report clinical outcome data, and the public record does not quantify the indication-statement differences the summary calls non-critical.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 23, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262067
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- SI-BONE, INC.
- Product code
- NKB
- Decision code
- SESE
- Decision date
- Sep 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Thoracolumbosacral Pedicle Screw System.
- Applicant
- SI-BONE, INC.
- Product code
- NKB
- FDA device class
- 2
FDA decision timeline
K262067 received
Application receipt date recorded by FDA.
K262067 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NKB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| SeaSpine Orthopedics Corporation | 510(k) clearance | Oct 29, 2026 | FDA | |
| GS Medical Co., Ltd. | 510(k) clearance | Oct 2, 2026 | FDA | |
NOVIX Pedicle Screw SystemK263062 | Tdm Co., Ltd. | 510(k) clearance | Oct 1, 2026 | FDA |
Duet Spinal Fixation SystemK262712 | Duet Spine Holdings, LLC | 510(k) clearance | Sep 30, 2026 | FDA |
| Spinal Alignment Solutions, Inc. | 510(k) clearance | Sep 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
SI-BONE, INC.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Santa Clara, CA
Sources and methodology
- Original FDA record: K262067
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


